Vivo Capital

Vivo Capital as of March 31, 2017

Portfolio Holdings for Vivo Capital

Vivo Capital holds 23 positions in its portfolio as reported in the March 2017 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Aclaris Therapeutics (ACRS) 25.1 $85M 2.9M 29.82
Ascendis Pharma A S (ASND) 14.6 $50M 1.8M 28.00
Nabriva Therapeutics 14.2 $48M 4.0M 12.00
Codexis (CDXS) 7.5 $25M 5.3M 4.80
Eiger Biopharmaceuticals (EIGR) 6.0 $21M 1.8M 11.45
Advanced Accelerat spon ads each rep 2 ord 5.7 $19M 484k 39.86
Aimmune Therapeutics 4.9 $17M 763k 21.73
Strongbridge Bioph shs usd 4.2 $14M 3.0M 4.75
Capnia 3.1 $10M 15M 0.71
Biopharmx 1.9 $6.4M 13M 0.50
Trevena 1.9 $6.3M 1.7M 3.67
Akari Therapeutics 1.7 $5.8M 528k 11.07
Agile Therapeutics 1.4 $4.8M 1.5M 3.20
Aurinia Pharmaceuticals (AUPH) 1.3 $4.4M 600k 7.34
Foamix Pharmaceuticals 1.2 $4.2M 855k 4.95
Sierra Oncology 1.1 $3.7M 2.4M 1.53
Crispr Therapeutics (CRSP) 0.9 $3.2M 149k 21.77
Regenxbio Inc equity us cm (RGNX) 0.9 $3.2M 164k 19.30
Kalvista Pharmaceuticals (KALV) 0.7 $2.3M 300k 7.81
Dynavax Technologies (DVAX) 0.6 $2.1M 360k 5.95
Sunesis Pharmaceuticals Inc Ne 0.6 $2.1M 500k 4.10
Revance Therapeutics (RVNC) 0.5 $1.6M 77k 20.80
Capnia Inc Common Stock Warrants 0.0 $113k 944k 0.12